{"id":"https://openalex.org/W2006364971","doi":"https://doi.org/10.1517/14712598.2014.902929","title":"Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence","display_name":"Efficacy and safety profile of evolocumab (AMG145), an injectable inhibitor of the proprotein convertase subtilisin/kexin type 9: the available clinical evidence","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-24","ids":{"openalex":"https://openalex.org/W2006364971","doi":"https://doi.org/10.1517/14712598.2014.902929","mag":"2006364971","pmid":"https://pubmed.ncbi.nlm.nih.gov/24661068"},"language":"en","primary_location":{"id":"doi:10.1517/14712598.2014.902929","doi":"https://doi.org/10.1517/14712598.2014.902929","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14712598.2014.902929","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2006364971"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068440626","display_name":"Arrigo F.G. Cicero","orcid":"https://orcid.org/0000-0002-4367-3884","observed_orcids":["https://orcid.org/0000-0002-4367-3884"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Arrigo FG Cicero","raw_affiliation_strings":["S. Orsola-Malpighi University Hospital, Medical and Surgical Sciences Department, Internal Medicine Unit , Pad. 2, Via Albertoni 15, 40138 Bologna , Italy +39 3498558017 ; +39 0516826125 ; afgcicero@cardionet.it , arrigo.cicero@unibo.it","S. Orsola-Malpighi University Hospital, Medical and Surgical Sciences Department, Internal Medicine Unit,\nPad. 2, Via Albertoni 15, 40138 Bologna, Italy+39 3498558017"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Orsola-Malpighi University Hospital, Medical and Surgical Sciences Department, Internal Medicine Unit , Pad. 2, Via Albertoni 15, 40138 Bologna , Italy +39 3498558017 ; +39 0516826125 ; afgcicero@cardionet.it , arrigo.cicero@unibo.it","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]},{"raw_affiliation_string":"S. Orsola-Malpighi University Hospital, Medical and Surgical Sciences Department, Internal Medicine Unit,\nPad. 2, Via Albertoni 15, 40138 Bologna, Italy+39 3498558017","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082563303","display_name":"Elisa Tartagni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Elisa Tartagni","raw_affiliation_strings":["Bologna University, Medical and Surgical Sciences Department, Internal Medicine Unit, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bologna University, Medical and Surgical Sciences Department, Internal Medicine Unit, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079341225","display_name":"Sibel Ertek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sibel Ertek","raw_affiliation_strings":["Ankara Koru Hospital, Department of Endocrinology and Metabolic Diseases, Balgat- Ankara, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ankara Koru Hospital, Department of Endocrinology and Metabolic Diseases, Balgat- Ankara, Turkey","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.3731,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.92919496,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"14","issue":"6","first_page":"863","last_page":"868"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/evolocumab","display_name":"evolocumab","score":1.0},{"id":"https://openalex.org/keywords/pcsk9-inhibition","display_name":"PCSK9 inhibition","score":0.8659999966621399},{"id":"https://openalex.org/keywords/ldl-cholesterol-lowering","display_name":"LDL cholesterol lowering","score":0.8220000267028809},{"id":"https://openalex.org/keywords/statin-intolerance","display_name":"statin intolerance","score":0.6110000014305115},{"id":"https://openalex.org/keywords/apolipoprotein-b-100","display_name":"apolipoprotein B-100","score":0.9089999794960022},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.9980000257492065},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8109999895095825},{"id":"https://openalex.org/keywords/ldl-receptor-degradation","display_name":"LDL receptor degradation","score":0.574999988079071},{"id":"https://openalex.org/keywords/lipid-lowering-therapy","display_name":"lipid-lowering therapy","score":0.7160000205039978},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7519999742507935},{"id":"https://openalex.org/keywords/nasopharyngitis","display_name":"nasopharyngitis","score":0.828000009059906}],"concepts":[{"id":"https://openalex.org/C2778114629","wikidata":"https://www.wikidata.org/wiki/Q15623825","display_name":"Evolocumab","level":5,"score":0.9851818084716797},{"id":"https://openalex.org/C2778849439","wikidata":"https://www.wikidata.org/wiki/Q6397985","display_name":"Kexin","level":5,"score":0.9050894975662231},{"id":"https://openalex.org/C2778824825","wikidata":"https://www.wikidata.org/wiki/Q7250439","display_name":"Proprotein convertase","level":5,"score":0.8510873317718506},{"id":"https://openalex.org/C2780948078","wikidata":"https://www.wikidata.org/wiki/Q21130010","display_name":"PCSK9","level":5,"score":0.803318977355957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7228779196739197},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6064015030860901},{"id":"https://openalex.org/C2780902209","wikidata":"https://www.wikidata.org/wiki/Q4726914","display_name":"Alirocumab","level":5,"score":0.5706383585929871},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5063449144363403},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4805203378200531},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.43418318033218384},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.4098111689090729},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3491702973842621},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.3051939606666565},{"id":"https://openalex.org/C43554185","wikidata":"https://www.wikidata.org/wiki/Q425649","display_name":"LDL receptor","level":4,"score":0.2420957386493683},{"id":"https://openalex.org/C2780745583","wikidata":"https://www.wikidata.org/wiki/Q1316030","display_name":"Apolipoprotein A1","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000071449","descriptor_name":"Proprotein Convertase 9","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000960","descriptor_name":"Hypolipidemic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007279","descriptor_name":"Injections, Subcutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008078","descriptor_name":"Cholesterol, LDL","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D012697","descriptor_name":"Serine Endopeptidases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D043484","descriptor_name":"Proprotein Convertases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D043484","descriptor_name":"Proprotein Convertases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1517/14712598.2014.902929","doi":"https://doi.org/10.1517/14712598.2014.902929","is_oa":false,"landing_page_url":"https://doi.org/10.1517/14712598.2014.902929","pdf_url":null,"source":{"id":"https://openalex.org/S57380513","display_name":"Expert Opinion on Biological Therapy","issn_l":"1471-2598","issn":["1471-2598","1744-7682"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Biological Therapy","raw_type":"journal-article"},{"id":"pmid:24661068","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24661068","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on biological therapy","raw_type":"Journal Article"},{"id":"pmh:oai:cris.unibo.it:11585/396662","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11585/396662","pdf_url":null,"source":{"id":"https://openalex.org/S4306402579","display_name":"Archivio istituzionale della ricerca (Alma Mater Studiorum Universit\u00e0 di Bologna)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210117483","host_organization_name":"Istituto di Ematologia di Bologna","host_organization_lineage":["https://openalex.org/I4210117483"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W162053157","https://openalex.org/W166855314","https://openalex.org/W1964279010","https://openalex.org/W1972661406","https://openalex.org/W1976691226","https://openalex.org/W1977761476","https://openalex.org/W1978080134","https://openalex.org/W2013376629","https://openalex.org/W2040612932","https://openalex.org/W2042583787","https://openalex.org/W2049718801","https://openalex.org/W2064328378","https://openalex.org/W2065709862","https://openalex.org/W2066666645","https://openalex.org/W2067539811","https://openalex.org/W2096075279","https://openalex.org/W2099136586","https://openalex.org/W2103487568","https://openalex.org/W2103647780","https://openalex.org/W2106285889","https://openalex.org/W2108956796","https://openalex.org/W2119475560","https://openalex.org/W2138438666","https://openalex.org/W2145989124","https://openalex.org/W2168120041","https://openalex.org/W4238535045","https://openalex.org/W4246070374"],"related_works":["https://openalex.org/W1639836801","https://openalex.org/W2338970981","https://openalex.org/W2789328009","https://openalex.org/W2313857835","https://openalex.org/W2124565608","https://openalex.org/W1639136771","https://openalex.org/W1993868533","https://openalex.org/W2329449966","https://openalex.org/W1993334958"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Despite":[1],"the":[2,60,69],"proven":[3],"efficacy":[4],"of":[5,29,37,128,171],"statins,":[6,100],"they":[7],"are":[8],"often":[9],"reported":[10],"to":[11,14,68,103,108,114,120,132,138,157,167,193,199],"be":[12,133,179],"inadequate":[13],"achieve":[15],"low-density":[16],"lipoprotein":[17],"cholesterol":[18],"(LDL-C)":[19],"goals":[20],"(especially":[21],"in":[22,97,122,181],"high-risk":[23,195],"patients).":[24],"Moreover,":[25],"a":[26,43,56,123,168],"large":[27,163],"number":[28],"subjects":[30],"cannot":[31],"tolerate":[32],"statins":[33,158],"or":[34,96],"full":[35],"doses":[36],"these":[38],"drugs.":[39],"Thus,":[40],"there":[41],"is":[42,55,101,150],"need":[44,198],"for":[45,82],"additional":[46],"effective":[47],"LDL-C":[48,105,202],"reducing":[49],"agents.":[50],"AREAS":[51],"COVERED:":[52],"Evolocumab":[53,149,187],"(AMG145)":[54],"monoclonal":[57],"antibody":[58],"inhibiting":[59],"proprotein":[61],"convertase":[62],"subtilisin/kexin":[63],"type":[64],"9":[65],"that":[66,90],"binds":[67],"liver":[70],"LDL":[71],"receptor":[72],"and":[73,86,116,135,144,159],"prevents":[74],"it":[75,81],"from":[76,106,112,118],"normal":[77],"recycling":[78],"by":[79],"targeting":[80],"degradation.":[83],"Phase":[84],"I":[85],"II":[87],"trials":[88,183],"revealed":[89],"its":[91],"subcutaneous":[92],"injection,":[93],"either":[94],"alone":[95],"combination":[98],"with":[99,160,184],"able":[102],"reduce":[104],"40":[107],"80%,":[109],"apolipoprotein":[110],"B100":[111],"30":[113],"59%":[115],"lipoprotein(a)":[117],"18":[119],"36%":[121],"dose-dependent":[124],"manner.":[125],"The":[126],"incidence":[127],"side":[129],"effects":[130],"seems":[131],"low":[134,169],"mainly":[136],"limited":[137],"nasopharyngitis,":[139],"injection":[140],"site":[141],"pain,":[142],"arthralgia":[143],"back":[145],"pain.":[146],"EXPERT":[147],"OPINION:":[148],"an":[151,161,190],"innovative":[152],"powerful":[153],"lipid-lowering":[154],"drug,":[155],"additive":[156],"apparently":[162],"therapeutic":[164],"range":[165],"associated":[166],"rate":[170],"mild":[172],"adverse":[173],"events.":[174],"If":[175],"available":[176],"data":[177],"will":[178,188],"confirmed":[180],"long-term":[182],"strong":[185],"outcomes,":[186],"provide":[189],"essential":[191],"tool":[192],"treat":[194],"patients":[196],"who":[197],"reach":[200],"ambitious":[201],"target.":[203]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2006364971","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":9},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
